Downturn Concepts and Tools for Biotech Companies

JUNE 2022
Peter Kolchinsky, PhD   |   Tess Cameron   |   Dan Lepanto
Join Peter Kolchinsky (Managing Partner, RA Capital), Tess Cameron (Principal, RA Capital), and Dan Lepanto (Senior Managing Director, SVB Securities) for a candid discussion on the array of tools a biotech board can employ in the midst of the current market downturn (June 2022).

Slides are available here.